Chugai Pharmaceutic-Unsp ADRCHGCY
13F holders, Q3 2025 (September 30)8holders −4
0new positions
4sold out
$22.02avg. 13F price*
At the end of Q3 2025, 8 institutions reported holding Chugai Pharmaceutic-Unsp ADR (CHGCY) in their 13F filings, down 4 from Q2 2025. 0 opened new positions and 4 sold out. The largest holders were Sterling Capital Management LLC ($1.0M), Confluence Investment Management LLC ($959K) and Rhumbline Advisers ($612K).
- Company
- Chugai Pharmaceutic-Unsp ADR
- CUSIP
- 171269103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 4 | $326K |
All 13F filers, Q2 2025 → Q3 2025: 4,312 shares bought and 41,352 shares sold, net −37,040 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Sterling Capital Management LLC | 0.02% | Reduce -35.7% | 47,171 | $1.0M |
| Confluence Investment Management LLC | 0.01% | Add +9.7% | 43,388 | $959K |
| Rhumbline Advisers | 0.00% | Reduce -1.4% | 27,682 | $612K |
| GAMMA Investing LLC | 0.01% | Reduce -2.8% | 10,675 | $236K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -15.0% | 10,600 | $234K |
| Salomon & Ludwin, LLC | 0.00% | Add +2572.2% | 481 | $11K |
| Hantz Financial Services, Inc. | 0.00% | Reduce -25.4% | 297 | $7K |
| Accent Capital Management, LLC | 0.00% | No change | 200 | $4K |
"% of holder's portfolio" is CHGCY's weight in each manager's 13F, not the share of Chugai Pharmaceutic-Unsp ADR the manager owns.